AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of the Benefit of the Mobility Assistance System (SAM) on Transfer Independence for a Reimbursement Request

RecruitingNAAges 18 Years - anyAllWINNCARE
💬

In plain words

What the trial is, and whether it could suit you

This is a randomized, cross-over, multi-center, intention-to-treat, open-label study to assess the impact of the SAM Ergonom light (SAM) device on independence when transferring from the supine to the sitting position at the edge of the bed in a population of individuals with an inability to transfer independently from the supine to the sitting position in bed, compared with the use of a raising arm.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Aged 18 and over * Unable to transfer from lying to sitting independently * Requiring technical assistance or the help or supervision of a third party * Using a medical bed * In-patient care for a minimum of 3 weeks in a medical or rehabilitation facility * Having freely consented to participate * Affiliated with a social security scheme or entitled to benefits Exclusion Criteria: * Non-consolidated spinal or pelvic fracture * Degenerative shoulder * Cardiovascular disorders caused by physical exertion * Joint pain localized to dorsolumbar spine * Behavioural disorders (opposition, agitation, dementia) * Invalid patient (disability, low tonicity), agitated, not lucid (confused, disoriented) at risk of falling, requiring physical restraint with bed rails on medical prescription * Functional inability to move independently * Cognitive impairment affecting reliability of response to questionnaires * Motor or algic incapacity of the 2 upper limbs not allowing the use of a technical aid (lifting frame or SAM) to ensure transfer from lying to sitting position in bed * Patient less than 146 cm tall * Patient weighing less than 30 kg or more than 200 kg * Patient with a mattress incompatible with the OS'CARE device * Mattress length less than 190 cm or greater than 200 cm, and width less than 85 cm or greater than 120 cm In addition, vulnerable persons covered by articles L. 1121-5 to 8 and L. 1122-1-2 of the French Public Health Code are excluded from the study: * Pregnant, parturient or breast-feeding women * Persons deprived of their liberty by judicial decision (including guardianship, curatorship and safeguard of justice) or administrative decision * Persons under psychiatric care or admitted to a health or social institution for purposes other than research. * Person in an emergency situation unable to give prior consent
💊

What it tests

  • SAM device (experimental): a removable structure, fixed to the horizontal frame of the medical bed, equipped with a handle to assist the sitting-up process
  • Over bed pole hoist (control device)
📍

Where

3 sites
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles (CMRRF) de Kerpape
Ploemeur, France
Fondation Ildys
Ploemeur, France
Pôle Saint Hélier
Rennes, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy